Literature DB >> 21883863

Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy.

Hwang Gyun Jeon1, In Hyuck Gong, Jin Ho Hwang, Don Kyung Choi, Seung Ryeol Lee, Dong Soo Park.   

Abstract

UNLABELLED: Study Type - Prognosis (case series) Level of Evidence 4 What's known on the subject? and What does the study add? At present, many studies have been executed to identify predictors for chronic kidney disease or renal insufficiency after radical nephrectomy or partial nephrectomy. We examined whether preoperative kidney volume is a predictor for renal function after radical or partial nephrectomies in RCC patients. To our knowledge, this is the first study to report on the relationship between preoperative kidney volume and changes in renal function in RCC patients who underwent radical nephrectomy or partial nephrectomy performed by one surgeon.
OBJECTIVE: To investigate whether preoperative kidney volume is a prognostic factor for predicting the postoperative glomerular filtration rate (GFR) in renal cell carcinoma (RCC) patients. PATIENTS AND METHODS: We included 133 patients who underwent radical (n= 83) or partial (n= 50) nephrectomy for RCC. Kidney parenchymal volume was measured using personal computer-based software and GFR was estimated before and after surgery at 6 and 12 months. We evaluated the change in kidney volume after radical and partial nephrectomy and used regression analysis to identify predictors of lower post-surgical GFR at 12 months.
RESULTS: The mean volume of the normal side kidney for the radical nephrectomy group increased from 142.4 mL to 166.0 mL (17.2%) and 171.5 mL (21.2%) after surgery at 6 and 12 months, respectively. In the partial nephrectomy group, the volume of the normal side kidney increased from 127.2 mL to 138.8 mL (9.1%) and 140.6 mL (10.9%) after surgery at 6 and 12 months, respectively. The volume of the operated side kidney decreased from 128.5 mL to 102.3 mL (20.1%) and 101.8 (20.6%) after surgery at 6 and 12 months, respectively. In the radical nephrectomy group, older age (P < 0.001), preoperative volume of the normal kidney (P= 0.022) and preoperative GFR for the normal side kidney (P= 0.045) were significant predictors of lower post-surgical GFR at 12 months. In the partial nephrectomy group, older age (P= 0.001) and preoperative volume for both kidneys (P= 0.037) were significant predictors of lower post-surgical GFR at 12 months.
CONCLUSION: Preoperative kidney volume is an independent predictor of GFR in RCC patients who underwent radical or partial nephrectomy.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21883863     DOI: 10.1111/j.1464-410X.2011.10531.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  25 in total

1.  Volumetric measurement of compensatory hypertrophy in the contralateral normal kidney by the tumor growth.

Authors:  Bong Hee Park; Byong Chang Jeong; Seong Soo Jeon; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Hwang Gyun Jeon
Journal:  World J Urol       Date:  2015-04-03       Impact factor: 4.226

2.  Estimating renal volume from CT: Is this is easiest way?

Authors:  Hwang Gyun Jeon
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

3.  A simple method to estimate renal volume from computed tomography.

Authors:  Rodney H Breau; Edward Clark; Bryan Bruner; Patrick Cervini; Thomas Atwell; Greg Knoll; Bradley C Leibovich
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

4.  Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Authors:  Raouf Seyam; Mahmoud I Khalil; Mohamed H Kamel; Waleed M Altaweel; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-01-08       Impact factor: 2.370

5.  Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma.

Authors:  Bong Hee Park; Hyun Hwan Sung; Byong Chang Jeong; Seong Ii Seo; Seong Soo Jeon; Hyun Moo Lee; Han Yong Choi; Hwang Gyun Jeon
Journal:  Int Urol Nephrol       Date:  2016-02-26       Impact factor: 2.370

6.  Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer.

Authors:  Daniel Vergho; Maximilian Burger; Moritz Schrammel; Sabine Brookman-May; Michael Gierth; Bernd Hoschke; Kai Lopau; Christian Gilfrich; Hubertus Riedmiller; Ingmar Wolff; Matthias May
Journal:  World J Urol       Date:  2014-10-25       Impact factor: 4.226

7.  A useful method for assessing differences of compensatory hypertrophy in the contralateral kidney before and after radical nephrectomy in patients with renal cell carcinoma: ellipsoid formula on computed tomography.

Authors:  Bong Hee Park; Kang Jun Cho; Jung Im Kim; Sang Rak Bae; Yong Seok Lee; Sung Hak Kang; Joon Chul Kim; Chang Hee Han
Journal:  Br J Radiol       Date:  2017-12-22       Impact factor: 3.039

8.  Relationship of renal morphology on 3-dimensional ultrasonography with renal pathologic findings and outcome in biopsy-proven nephropathy.

Authors:  Jianwei Xu; Sung Il Hwang; Hak Jong Lee; Ho Jun Chin
Journal:  Exp Ther Med       Date:  2017-12-13       Impact factor: 2.447

9.  Predictive factors for the development of chronic renal insufficiency after renal surgery: a multicenter study.

Authors:  Yong Sun Choi; Yong Hyun Park; Yong-June Kim; Seok Ho Kang; Seok-Soo Byun; Sung-Hoo Hong
Journal:  Int Urol Nephrol       Date:  2013-09-27       Impact factor: 2.370

10.  Validation of 3D volumetric-based renal function prediction calculator for nephron sparing surgery.

Authors:  Renato Corradi; Aashish Kabra; Melissa Suarez; Jacob Oppenheimer; Zhamshid Okhunov; Hugh White; Stephanie Nougaret; Hebert A Vargas; Jaime Landman; Jonathan Coleman; Michael A Liss
Journal:  Int Urol Nephrol       Date:  2017-02-04       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.